SCI Pharmtech Inc (4119) — Cash Flow Reinvestment Rate
SCI Pharmtech Inc (4119) has a Cash Flow Reinvestment Rate of 1.56x as of December 2025, reinvesting NT$98.02 Million (capex NT$98.02 Million ) from operating cash flow of NT$62.91 Million. Explore reinvestment intensity of SCI Pharmtech Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SCI Pharmtech Inc Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for SCI Pharmtech Inc across 23 annual periods. Also explore 4119 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for SCI Pharmtech Inc (2002–2025)
Year-by-year capital reinvestment analysis for SCI Pharmtech Inc. For live market cap and broader valuation context, see SCI Pharmtech Inc (4119) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.21x | NT$707.54 Million | NT$220.32 Million | NT$610.00 Million | ▲ +183.7% |
| 2024 | 1.13x | NT$974.05 Million | NT$860.52 Million | NT$946.64 Million | ▼ -87.1% |
| 2023 | 8.79x | NT$1.90 Billion | NT$215.77 Million | NT$1.03 Billion | ▲ +19.7% |
| 2022 | 7.34x | NT$2.18 Billion | NT$296.56 Million | NT$1.17 Billion | ▲ +103.2% |
| 2021 | 3.61x | NT$1.01 Billion | NT$280.28 Million | NT$774.98 Million | ▲ +706.1% |
| 2020 | 0.45x | NT$435.34 Million | NT$971.53 Million | NT$217.70 Million | ▲ +32.5% |
| 2019 | 0.34x | NT$267.76 Million | NT$791.60 Million | NT$204.49 Million | ▼ -21.2% |
| 2018 | 0.43x | NT$206.20 Million | NT$480.18 Million | NT$162.44 Million | ▼ -55.9% |
| 2017 | 0.97x | NT$273.96 Million | NT$281.65 Million | NT$147.39 Million | ▲ +16.8% |
| 2016 | 0.83x | NT$418.32 Million | NT$502.11 Million | NT$177.20 Million | ▲ +15.5% |
| 2015 | 0.72x | NT$478.51 Million | NT$663.24 Million | NT$217.51 Million | ▼ -44.0% |
| 2014 | 1.29x | NT$462.15 Million | NT$358.77 Million | NT$369.15 Million | ▼ -62.8% |
| 2013 | 3.46x | NT$826.27 Million | NT$238.57 Million | NT$773.01 Million | ▲ +638.2% |
| 2012 | 0.47x | NT$180.90 Million | NT$385.57 Million | NT$180.90 Million | ▼ -20.7% |
| 2011 | 0.59x | NT$147.71 Million | NT$249.55 Million | NT$147.71 Million | ▼ -31.9% |
| 2010 | 0.87x | NT$190.34 Million | NT$218.96 Million | NT$190.34 Million | ▲ +52.1% |
| 2009 | 0.57x | NT$181.13 Million | NT$316.96 Million | NT$181.13 Million | ▲ +1.5% |
| 2008 | 0.56x | NT$138.12 Million | NT$245.29 Million | NT$138.12 Million | ▼ -43.6% |
| 2007 | 1.00x | NT$167.21 Million | NT$167.53 Million | NT$167.21 Million | ▼ -18.9% |
| 2006 | 1.23x | NT$162.00 Million | NT$131.62 Million | NT$162.00 Million | ▲ +165.3% |
| 2004 | 0.46x | NT$35.55 Million | NT$76.61 Million | NT$35.55 Million | ▼ -4.3% |
| 2003 | 0.48x | NT$100.29 Million | NT$206.86 Million | NT$100.29 Million | ▲ +24.4% |
| 2002 | 0.39x | NT$41.73 Million | NT$107.12 Million | NT$41.73 Million | — |